BioNeutral Group Inc. (fka BONU)

[21ZNA9]

10 MILLION in TOXIC FINANCING COMING:

On December 11, 2012, the Company entered into an Equity Purchase Agreement (“Equity Line of Credit”) with Southridge Partners II, LP (“Southridge”) for an equity line of up to $10,000,000. Pursuant to the Equity Purchase Agreement, the Company has the right, at its discretion, to sell to Southridge up to $10 million of its common stock from time to time over a 36-month period. The Company will have the right, but is not obligated, to sell stock to Southridge depending on certain conditions as set forth in the Agreement. The Company submitted a registration statement to the SEC and is currently engaged in the process of responding to comments received from the SEC. The Company cannot begin utilizing the Equity Line of Credit until approval is granted by the SEC.


http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9510639